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Abstract
Background: In resource poor settings where automated hematology analyzers are not available, the
Cyanmethemoglobin method is often used. This method though cheaper, takes more time. In blood
donations, the semi-quantitative gravimetric copper sulfate method which is very easy and inexpensive may
be used but does not provide an acceptable degree of accuracy. The HemoCue
® hemoglobin photometer
has been used for these purposes. This study was conducted to generate data to support or refute its use as
a point-of-care device for hemoglobin estimation in mobile blood donations and critical care areas in health
facilities.
Method: EDTA blood was collected from study participants drawn from five groups: pre-school children, school
children, pregnant women, non-pregnant women and men. Blood collected was immediately processed to
estimate the hemoglobin concentration using three different methods (HemoCue
®, Sysmex KX21N and
Cyanmethemoglobin). Agreement between the test methods was assessed by the method of Bland and Altman.
The Intraclass correlation coefficient (ICC) was used to determine the within subject variability of measured
hemoglobin.
Results: Of 398 subjects, 42% were males with the overall mean age being 19.4 years. The overall mean
hemoglobin as estimated by each method was 10.4 g/dl for HemoCue, 10.3 g/dl for Sysmex KX21N and 10.3 g/dl
for Cyanmethemoglobin. Pairwise analysis revealed that the hemoglobin determined by the HemoCue method
was higher than that measured by the KX21N and Cyanmethemoglobin. Comparing the hemoglobin determined
by the HemoCue to Cyanmethemoglobin, the concordance correlation coefficient was 0.995 (95% CI: 0.994-0.996, p
< 0.001). The Bland and Altman’s limit of agreement was -0.389 - 0.644 g/dl with the mean difference being 0.127
(95% CI: 0.102-0.153) and a non-significant difference in variability between the two measurements (p = 0.843).
After adjusting to assess the effect of other possible confounders such as sex, age and category of person, there
was no significant difference in the hemoglobin determined by the HemoCue compared to Cyanmethemoglobin
(coef = -0.127, 95% CI: -0.379 - 0.634).
Conclusion: Hemoglobin determined by the HemoCue method is comparable to that determined by the other
methods. The HemoCue photometer is therefore recommended for use as on-the-spot device for determining
hemoglobin in resource poor setting.
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Hemoglobin (Hb) assessments are the most reliable indi-
cator widely used to screen individuals for anaemia, to
draw inferences about the iron status of populations and
to evaluate responses to nutritional interventions [1]. The
blood Hb concentration is an important variable direct-
ing transfusion therapy in patients suffering major blood
loss due to accidents, surgery, labour and many other cri-
tical conditions [2]. Hb concentration is measured routi-
nely using automated hematology analyzers, such as
those produced by the Sysmex Corporation (Kobe,
Japan). Although these counters are very accurate and
reliable, they are expensive and transport of the samples
to the laboratory delays the process which may delay
treatment, resulting in preventable deaths [3]. In resource
poor settings where automated hematology analyzers are
not available, the Cyanmethemoglobin method is often
used. Hb estimation by this method though cheaper than
the automated method takes more time [4]. In blood
donations, the semi-quantitative gravimetric copper sul-
fate method which is very easy and inexpensive may be
used, but does not provide an acceptable degree of accu-
racy [5,6]. The HemoCue
® Hb photometer has been
widely used for these purposes in recent years [7] because
it is portable, requires only a small sample of capillary/
venous blood, is relatively inexpensive and simple to use,
does not require access to refrigeration or even electri-
city, and gives immediate, digitally displayed results [3].
However, data to support the use of this device for all
categories of patients in resource limited areas of Ghana
is not available. This study was therefore conducted to
generate data to support or refute its use as a point-of-
care device for Hb estimation, mobile blood donations
and critical care areas in health facilities.
Methods
Study Subjects
A total of 398 consented study patients were involved in
this study. They were placed in five groups: pre-school
children (subjects within 1-4 years), school children
(subjects within 5-14 years), pregnant women (No age
limit), non-pregnant women (female subjects within 15-
59 years) and men (male subjects within 15-59 years).
Study Design
This was a hospital-based study conducted at the
Agogo Presbyterian Hospital in the Asante Akim
North District (AAND), Ashanti Region, Ghana. Blood
samples were collected from consented participants
within the study group reporting to the hospital after
study procedures had been explained to them. EDTA
blood samples taken from patients for routine labora-
tory investigations were used for the study thus no
extra blood was collected except for patients in which
EDTA blood was not taken, in which case venous
blood was taken from the arm. Venous blood collected
from participants was processed to estimate their Hb
content using three different methods (HemoCue
®,
Sysmex KX21N and Cyanmethemoglobin).
Study Site
The Agogo Presbyterian Hospital in Agogo was the
study site. This is the major hospital serving the Asante-
Akim North District and other parts of the Ashanti
region. The main departments of the hospital are the
Children’s, Casualty, Surgical, Medical, Obstetrics and
Gynecology, Eye and the laboratory Departments. The
laboratory department of the hospital offers diagnostic
as well as research services. The department is fully
equipped and has functional Microbiology, Hematology,
Parasitology and Clinical Chemistry departments. The
laboratory participates in various External Quality
Assessment programmes one of which is the United
Kingdom National External Quality Assessment Service
(UK NEQAS) in hematology. Among the most prevalent
diseases in the district are malaria, buruli ulcer, typhoid
fever and tuberculosis.
Ethical Approval
Ethical approval for this study was obtained from the
Committee on Human Research, Publication and Ethics
(CHRPE), of the School of Medical Sciences, KNUST-
Kumasi. After information and appropriate explanations,
adults or parents/legal guardians of children willing to
participate in the study had to give their consent by
appending their signature or thumbprint to the
informed consent form before any study related proce-
dures were done.
HemoCue
® Portable Photometer
The HemoCue
® B-Hemoglobin system (HemoCue AB,
Ängelholm, Sweden) consistso fd i s p o s a b l em i c r o c u v -
ettes containing reagent in a dry form and a single pur-
pose designed photometer. The microcuvettes were
s t o r e di nad r yp l a c ea tr o o mt e m p e r a t u r e .O n c e
opened, they were tightly closed and stored at the same
conditions to maintain their integrity and shelf life. The
reaction in the microcuvette is a modified azide-methe-
moglobin reaction. Sodium deoxycholate haemolyses
erythrocytes and hemoglobin is released. Sodium nitrite
converts hemoglobin to methemoglobin which, together
with sodium azide, gives azidemethemoglobin. The
absorbance is measured at two wavelengths (570 nm
and 880 nm) in order to compensate for turbidity in the
sample. The test was performed as stated by the manu-
facturer [8].
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The Sysmex KX21N (Sysmex Corporation, Kobe, Japan)
is an automated blood cell counter intended for in vitro
diagnostic use in clinical laboratories. It is a compact,
fully automated hematology analyzer with simultaneous
analysis of 18 parameters in whole blood mode and
capillary blood mode. It measures the hemoglobin con-
centration using a non-cyanide hemoglobin method
(STROMATOLYSER WH). The instrument has been
proven to provide accurate and reliable results including
hemoglobin concentrations [9,10]. The test was per-
formed as stated in the manufacturer’s manual [11].
Cyanmethemoglobin Method
The principle of this method lies in conversion of
hemoglobin to cyanmethemoglobin by the addition of
Potassium cyanide and ferricyanide whose absorbance is
measured at 540 nm in a photoelectric calorimeter
against a standard solution. The test was performed as
outlined by Bhaskaram et al [12].
Quality Control
The function of the HemoCue photometer was checked
on a daily basis by measuring the control cuvette (Serial
no: 0214-003 071) and a standard of known concentra-
tion. A three set EIGHTCHECK-3WP controls (Low,
Normal and High) were run daily to ensure the function
of the Sysmex KX21N. For the cyanmethemoglobin, a
hemoglobin standard of known concentration was tested
daily. Samples were only processed when the QC mate-
rial had passed.
Statistical Analysis
Data was double-entered into a predesigned electronic
database using Epi info version 6.04 (Center for Disease
Control, Atlanta, GA, USA) and cleaned on a regular
basis. It was then exported to Stata/SE10.1 statistical
software (Stata Corporation, Texas USA) for analysis. A
pairwise t-test was used to compare the HemoCue and
both the Sysmex and cyanmethemoglobin. Agreement
between the test methods was assessed by the method
of Bland and Altman [13], where the mean, standard
deviation and limit of agreement of paired results were
calculated. Figures plotting difference against the aver-
age were graphed as Bland and Altman recommended
[13]. The Intraclass correlation coefficient (ICC) was
used to determine the within subject variability of mea-
sured hemoglobin whiles the concordance correlation
coefficient (CCC) was used to measure the agreement
between the three methods.
Results
T h es t u d yw a sc a r r i e do u tf r o mA u g u s tt oD e c e m b e r
2010. Three hundred and ninety eight consented study
subjects were recruited for the study. Of these, school
children constituted the highest population (22.4%)
whilst adult males constituted the least (16.6%). Overall,
there were fewer males (42%) than females. Whilst adult
males had the highest mean age of 34.3 years (range:
16-59 years), pre-school children recorded the least with
2.3 years (range: 1-4 years), with the overall mean age
being 19.4 years (range: 1-64 years) (Table 1).
There was a significant but marginal increase in
hemoglobin with age (0.03 g/dl/year, p < 0.001). Pre-
school and school children recorded the lowest mean
hemoglobin concentration of 9.2 g/dl (SD: 2.9) and 9.7
g/dl (SD: 3.1) respectively. This was followed by non-
pregnant and pregnant women with mean hemoglobin
of 10.7 g/dl (SD: 2.4) and 11.0 g/dl (SD: 1.7) respec-
tively. Adult males had the highest mean hemoglobin of
11.3 g/dl (SD: 3.3). The mean hemoglobin concentration
of males was 0.5 g/dl (95%CI: 0.1 to 0.8 g/dl, p = 0.01),
higher than that of the females. This effect persisted
even after correcting for the age, method used to esti-
mate hemoglobin and study sub-population. Pairwise
analysis revealed that the hemoglobin determined by the
HemoCue method was higher than that measured by
the KX21N and Cyanmethemoglobin with mean differ-
ences of 0.15 g/dl (95% CI: 0.12 to 0.17, p < 0.001) and
0.13 g/dl (95%CI: 0.10 to 0.15, p < 0.001) respectively.
That measured by the KX21N and Cyanmethemoglobin
methods were however not significantly different (0.02
g/dl, 95%CI: 0.00 to 0.04, p = 0.10).
There was near perfect concordance correlation
between the hemoglobin concentrations determined by
the HemoCue and Cyanmethemoglobin methods (rho =
0.995) as well as HemoCue and KX21N (0.994). These
were not significantly different for that between KX21N
and the Cyanmethemoglobin method (0.997) (Table 2).
Comparing the hemoglobin concentration determined
by the HemoCue and Cyanmethemoglobin, the Bland
and Altman’s limit of agreement was from -0.39 to 0.64
g/dl with the mean difference being 0.13, and a non-sig-
nificant difference in variability between the two mea-
surements (p = 0.843). For HemoCue and KX21N, the
Bland and Altman’s limit of agreement was from -0.39
to 0.69 g/dl with a mean difference of 0.15 and a non-
significant difference in variability between the two mea-
surements (p = 0.391) (Figure 1, 2).
The within subject variability of measured hemoglobin
was very minimal with high intraclass correlation coeffi-
cient for all the various subgroups (Table 3). The lowest
intraclass coefficient was in pregnant women (0.986)
and the highest was in school children (0.997). These
coefficients were also associated with high estimated
reliabilities ranging between 0.995 and 0.999.
After adjusting to assess the effect of other possible
confounders such as sex, age and category of person,
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determined by the HemoCue compared to Cyanmethe-
moglobin (coef = -0.127, 95%CI: -0.379 - 0.634) and that
by HemoCue compared to Sysmex KX21N (coef =
-0.147, 95%CI: -0.676 - 0.382).
Discussion
Accurate determination of hemoglobin concentration is
a common element in assessing the extent of anemia
and making a decision whether transfusion is necessary
or not. This decision should be made based on reliable
and rapidly assessed laboratory tests. In settings where a
central laboratory is used for the purposes of testing
and transfusion monitoring, the time loss for blood sam-
ple transportation create delays which may lead to the
loss of lives[3,12].
The HemoCue is a portable device for measuring
hemoglobin concentration [14] and it requires very little
staff training thus making it a very useful tool in
resource limited areas, critical care areas such as the
theatre, pediatric ward, maternity, intensive care units
etc as well as at field conditions since it can easily be
transported. In this study, we compared it with the
Cyanmethemoglobin method and the Sysmex KX21N
used in the laboratory. We found no significant differ-
ences in the hemoglobin concentrations determined by
all the three methods, with no perceptible trend for dis-
agreement with high or low values. The three devices
had comparable concordance correlation coefficient,
limits of agreement and intraclass correlation coeffi-
cients thus supporting the use of the HemoCue portable
photometer among the various study groups in our
study setting.
Our study is in agreement with other studies con-
ducted in other settings to support the use of the device.
These include the studies conducted by von Schenck et
al [15], Van de Louw et al; among patients with gastro-
intestinal bleeding [16], Rippmann et al; among surgical
Table 1 Summary of subject categories in the various subgroups
Study Subgroup
School Children Pre-School Children Pregnant Women Adult Men Non-pregnant Women Overall
Number (%) 89 (22.4) 87 (21.9) 73 (18.3) 66 (16.6) 83 (20.8) 100
Male n (%) 51 (57.5) 50 (57.5) 0 66 (100.0) 0 167 (42.0)
Age in years
Mean (SD) 7.8 (2.3) 2.3 (1.1) 27.2 (5.8) 34.3 (12.3) 30.9 (11.7) 19.4 (15.2)
95% CI 7.3-8.3 2.1-2.6 25.8-28.6 31.2-37.3 28.4-33.5 17.9-20.9
Range 5-14 1-4 17-41 16-59 12-64 1-64
Hb(g/dl) by HemoCue
Mean (SD) 9.8 (3.1) 9.3 (2.9) 11.1 (1.7) 11.4 (3.3) 10.8 (2.5) 10.4 (2.8)
95% CI 9.1-10.4 8.7-9.9 10.7-11.5 10.6-12.2 10.3-11.3 10.1-10.7
Range 3.3-20.3 2.7-16.8 5.6-16.6 3.2-16.8 2.9-16.7 2.7-20.3
Hb(g/dl) by KX21N
Mean (SD) 9.6 (3.1) 9.1 (2.9) 10.9 (1.6) 11.3 (3.4) 10.7 (2.4) 10.2 (2.9)
95% CI 8.9-10.3 8.5-9.8 10.5-11.3 10.4-12.1 10.1-11.2 10.0-10.5
Range 2.7-20.4 2.4-16.9 5.5-16.0 3.3-16.9 2.9-16.6 2.4-20.4
Hb(g/dl) by Cyanmethemoglobin
Mean (SD) 9.6 (3.1) 9.2 (2.9) 11.0 (1.7) 11.3 (3.3) 10.7 (2.5) 10.3 (2.8)
95% CI 9.0-10.3 8.6-9.8 10.6-11.4 10.4-12.1 10.1-11.2 10.0-10.5
Range 2.9-20.4 2.5-16.4 5.5-16.3 3.0-16.7 2.7-16.5 2.5-20.4
Table 2 Bland and Altman methods comparison
Hemo
¥ vrs Cyan* Hemo vrs KX21N Cyan vrs KX21N
Bland and Altman
Limit of agreement (p-value) - 0.39 to 0.64 (0.843) - 0.39 to 0.69 (0.39) - 0.45 to 0.49 (0.441)
Mean difference (95%CI) 0.13 (0.10 to 0.15) 0.15 (0.120 to 0.174) 0.02 (-0.00 to 0.04)
Concordance Correlation Coefficient
rho (95% CI) 0.995 (0.994 to 0.996) 0.994 (0.993 to 0.995) 0.997 (0.996 to 0.997)
p-value <0.001 <0.001 <0.001
¥ HemoCue * Cyanmethemoglobin
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one sample [7], Neville; within urban general practice
[18], Rechner et al; among neonates [19], Lardi et al;
among patients undergoing aortic surgery in the theatre
[14], Sari et al; among Indonesian mothers [4] and
Radtke et al; among blood donors [20].
Nevertheless, other studies such as that conducted by
Zhou et al; among pregnant women in a higher altitude
area of Tibet, China [21] and Bhaskaram et al; among
apparently healthy children of 1-6 years [12] do not sup-
p o r tt h eu s eo ft h eH e m o C u ei nt h e i rv a r i o u ss t u d y
populations.
The cyanrnethemoglobin method is a widely used
method of estimating Hb. However, several reports indi-
cate that results obtained using this method could be
imprecise due to a number of factors: turbidity of the
blood and the large dilution of the sample (20 μLo f
blood in 5 mL of Drabkin’s solution) [22-24], it requires
skillful technical operations in terms of accurate uptake
of the blood volume into a calibrated hemoglobin pip-
ette, careful mixing of the sample with the Drabkin’s
solution, measurement of absorbance in the photometer
and calculation of actual value from a systematically
constructed standard graph [12]. All these manual
o p e r a t i o n sa r et i m ec o n s u m i n ga n dm a k et h em e t h o d
unsuitable for large scale field/community studies. It is
also well documented that conditions such as hyperlipe-
mia [23] and Waldenstrom’s macroglobulinemia [25]
can cause falsely high results for hemoglobin in the filter
photometer method such as the cyanmethemoglobin
method.
T h eH e m o C u ei sap o r t a b l em a c h i n ew h i c hd i r e c t l y
measures Hb from an undiluted blood sample [8] and
background turbidity of the samples are corrected due
to the measurement of two-wave lengths [15]. This
method is quicker (60 seconds), simple to operate thus
making it faster with a shorter turn-around time. In
addition, it requires less blood (10 μL), is cost effective
and a more accurate method [12,16,19] as well as having
other properties as stated by Sari et al [4] and Sawant et
al [26]. Issues of cost have also been being reported as a
factor to take into account when considering Hb estima-
tion with the HemoCue [4,18,26]. The mechanical filling
of the cuvettes with 10 μl of the blood by capillary
action avoids several manual errors which often occur
in the collection, dilution and measurement of the sam-
ple in the cyanmethemoglobin method. Nevertheless,
the presence of air bubbles, excess blood on the back of
the cuvettes, over filling of the cuvettes and insufficient
mixing of the samples may lead to erroneous results.
These factors even though reduced to the barest mini-
mum might have contributed to the higher Hb concen-
tration observed in our study as also reported in other
studies [14,15,17,18]. However, by offering adequate
training on the technique of proper filling the cuvettes
to avoid air bubbles and over filling, mixing samples
adequately but gently and wiping off excess blood from
the cuvettes without reducing the blood quantity, these
errors can be easily avoided.
Conclusion
Hemoglobin determined by the HemoCue method is
comparable to that determined by both the Cyanmethe-
moglobin and Sysmex KX21N methods. The HemoCue
photometer is therefore recommended for use as on-
the-spot device for determining hemoglobin in resource
Figure 1 Bland and Altman plot for HemoCue and
Cyanmethemoglobin. Mean of HemoCue and
Cyanmethemoglobin (g/dl).
Figure 2 Bland and Altman plot for HemoCue and Sysmex
KX21N. Mean of HemoCue and Sysmex (g/dl).
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facilities.
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Table 3 Within subject analysis of measured Hb for various study populations
Study Subgroup
School Children Pre-School Children Pregnant Women Adult Men Non-pregnant Women
Intraclass correlation
Coefficient 0.997 0.995 0.986 0.996 0.993
95% CI 0.996 to 0.998 0.994 to 0.997 0.980 to 0.991 0.995 to 0.998 0.990 to 0.995
Estimated Reliability 0.999 0.998 0.995 0.999 0.998
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